[13C6]-Nafamostat formate salt
Catalog Number |
ACMA00065279 |
Description |
Nafamostat is intended for Pharmaceuticals applications. Nafamostat mesylate is used in the treatment of disseminated intravascular coagulation (DIC), pancreatitis, and systemic inflammatory response syndrome. Nafamostat mesylate is involved in the development of immune activity. All information about [13C6]-Nafamostat formate salt is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. |
Molecular Weight |
445.35 |
Molecular Formula |
C19H17N5O2·2HCOOH |
Purity |
≥90% |
Isotopic Enrichment |
99% 13C |
Stability |
≥1 year |
Unlabeled CAS |
Free base: 81525-10-2 |
Please kindly note that our products and services are for research use only.